Literature DB >> 29716746

The Benzodiazepine Binding Sites of GABAA Receptors.

Erwin Sigel1, Margot Ernst2.   

Abstract

Everyday activity is based on a subtle equilibrium of excitatory and inhibitory neuronal systems. The most prominent players in neuronal inhibition are synaptic and extrasynaptic GABAA receptors. Benzodiazepines are popular drugs that act as positive allosteric modulators of a subset of these receptors. Benzodiazepines have sedative, hypnotic, muscle-relaxant, and anticonvulsive effects, and are of outstandingly low overdose risk. The discovery of a large number of subtypes of GABAA receptors has raised hopes for a clear separation of this spectrum of actions. We discuss here how far this separation has been achieved, and outline recent progress towards the discovery of novel ligands for canonical and non-canonical binding sites.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GABA; GABA(A) receptor; benzodiazepine; receptor subtypes

Mesh:

Substances:

Year:  2018        PMID: 29716746     DOI: 10.1016/j.tips.2018.03.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  43 in total

Review 1.  Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders.

Authors:  Thomas Prévot; Etienne Sibille
Journal:  Mol Psychiatry       Date:  2020-04-28       Impact factor: 15.992

2.  Cryo-electron microscopy reveals informative details of GABAA receptor structural pharmacology: implications for drug discovery.

Authors:  Richard W Olsen; A Kerstin Lindemeyer; Martin Wallner; Xiaorun Li; Kevin W Huynh; Z Hong Zhou
Journal:  Ann Transl Med       Date:  2019-07

3.  Identifying Drugs that Bind Selectively to Intersubunit General Anesthetic Sites in the α1β3γ2 GABAAR Transmembrane Domain.

Authors:  Selwyn S Jayakar; Xiaojuan Zhou; David C Chiara; Carlos Jarava-Barrera; Pavel Y Savechenkov; Karol S Bruzik; Mariola Tortosa; Keith W Miller; Jonathan B Cohen
Journal:  Mol Pharmacol       Date:  2019-04-05       Impact factor: 4.436

4.  Mechanisms of inhibition and activation of extrasynaptic αβ GABAA receptors.

Authors:  Vikram Babu Kasaragod; Martin Mortensen; Steven W Hardwick; Ayla A Wahid; Valentina Dorovykh; Dimitri Y Chirgadze; Trevor G Smart; Paul S Miller
Journal:  Nature       Date:  2022-02-09       Impact factor: 49.962

Review 5.  The α9α10 nicotinic acetylcholine receptor: a compelling drug target for hearing loss?

Authors:  Ana Belén Elgoyhen
Journal:  Expert Opin Ther Targets       Date:  2022-03-07       Impact factor: 6.902

Review 6.  Regulation of GABAARs by Transmembrane Accessory Proteins.

Authors:  Wenyan Han; Ryan D Shepard; Wei Lu
Journal:  Trends Neurosci       Date:  2020-11-21       Impact factor: 13.837

7.  Dysfunction of Trio GEF1 involves in excitatory/inhibitory imbalance and autism-like behaviors through regulation of interneuron migration.

Authors:  Xiaoxuan Sun; Lifang Wang; Chengwen Wei; Mengwen Sun; Qiongwei Li; Hu Meng; Weihua Yue; Dai Zhang; Jun Li
Journal:  Mol Psychiatry       Date:  2021-05-07       Impact factor: 15.992

8.  Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation.

Authors:  Thomas D Prevot; Akiko Sumitomo; Toshifumi Tomoda; Daniel E Knutson; Guanguan Li; Prithu Mondal; Mounira Banasr; James M Cook; Etienne Sibille
Journal:  Cereb Cortex       Date:  2021-01-05       Impact factor: 5.357

Review 9.  From benzodiazepines to fatty acids and beyond: revisiting the role of ACBP/DBI.

Authors:  Thierry Alquier; Catherine A Christian-Hinman; Julieta Alfonso; Nils J Færgeman
Journal:  Trends Endocrinol Metab       Date:  2021-09-23       Impact factor: 12.015

Review 10.  Molecular mechanisms of metabotropic GABAB receptor function.

Authors:  Hamidreza Shaye; Benjamin Stauch; Cornelius Gati; Vadim Cherezov
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.